Cantel Medical (NYSE:CMD) and Censis Technologies today announced a new long-term partnership to combine Cantel’s endoscope reprocessing workflow portfolio with the Censis surgical device management and instrument-tracking software from Censis.

The new, co-branded product will combine Cantel’s Canexis integrated workflow software for endoscopy with Censis’ CensiTrac surgical asset management program. The combined software will provide quality management tools to help endoscopy customers use best practices for patient safety and infection prevention, according to a news release from Cantel. Incompletely reprocessed endoscopes have been associated with hospital-acquired infections (HAIs).

“We are thrilled to be partnering with Censis on this critical endeavor,” said Michael Spicer, president of Cantel’s medical business unit in the release. “By partnering with Censis, we are taking the next step toward providing greater efficiency, protection, and analytics to allow our customers to maximize their practice workflow while providing solutions designed to improve the safety and protection of their patients.”

“The relationship with Cantel will expand Censis’ leadership in surgical asset management and tracking solutions by further introducing innovative SaaS-based technology for the reprocessing of endoscopes,” added Censis CEO Randy Smith. “We are excited that the combined efforts of these two organizations will provide our customers opportunities to improve patient safety, workflow optimization and analytics.”